Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Hormonal therapies"'
Autor:
Allison B. Reiss, Shelly Gulkarov, Aaron Pinkhasov, Katie M. Sheehan, Ankita Srivastava, Joshua De Leon, Aaron E. Katz
Publikováno v:
Medicina, Vol 60, Iss 1, p 77 (2023)
Prostate cancer is the second leading cause of cancer death in men in the United States. Androgen deprivation therapy (ADT) is currently the primary treatment for metastatic prostate cancer, and some studies have shown that the use of anti-androgen d
Externí odkaz:
https://doaj.org/article/1c62c4c2ef224689a621f8353dfeb7cb
Autor:
Mayuko Murakami, Satoko Osuka, Ayako Muraoka, Shotaro Hayashi, Bayasula, Yukiyo Kasahara, Reina Sonehara, Yumi Hariyama, Kanako Shinjo, Hideaki Tanaka, Natsuki Miyake, Sayako Yoshita, Natsuki Nakanishi, Tomoko Nakamura, Maki Goto, Hiroaki Kajiyama
Publikováno v:
Reproductive Biology and Endocrinology, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Endometriosis is a complex syndrome characterized by an estrogen-dependent chronic inflammatory process that affects 10% of women of reproductive age. Ovarian endometriosis (OE) is the most common lesion in endometriosis and may c
Externí odkaz:
https://doaj.org/article/433c582f40344f0583e14bf0be379eab
Autor:
Daniele Langella
Publikováno v:
Medicina, Vol 59, Iss 6, p 1108 (2023)
Background and Objectives: Vulvovaginal atrophy (VVA) is a condition that affects a large number of women and can significantly impact their quality of life. While several treatments are currently available for VVA, there are potential risks associat
Externí odkaz:
https://doaj.org/article/9d598c9b28004f5798603160694a8a7b
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionEnzalutamide, apalutamide, and darolutamide have all been approved by Food and Drug Administration to treat high-risk non-metastatic castration-resistant prostate cancer (nmCRPC) since 2018 based on interim results of several phase III cl
Externí odkaz:
https://doaj.org/article/214a1433e1194ccb99ebcccd71b1892b
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 11, Pp 283-300 (2019)
Alberto Bretoni, Lucrezia Ferrario, Emanuela FogliaCentre for Health Economics, Social and Health Care Management, LIUC – Università Cattaneo, Castellanza, ItalyPurpose: To investigate the implications of the introduction of two hormonal therapies
Externí odkaz:
https://doaj.org/article/8c039c9df7574e4ca36155a5be576eaa
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Langella, Daniele
Publikováno v:
Medicina; Volume 59; Issue 6; Pages: 1108
Background and Objectives: Vulvovaginal atrophy (VVA) is a condition that affects a large number of women and can significantly impact their quality of life. While several treatments are currently available for VVA, there are potential risks associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::acf998f63c32994a2c2271b733304a7c
Autor:
O. I. Lisitsyna, E. G. Khilkevich
Publikováno v:
Медицинский совет, Vol 0, Iss 13, Pp 50-53 (2017)
The premenstrual syndrome (PMS) is a complex pathological symptom manifesting itselft through variety of neuropsychiatric, vegetative-vascular and metabolic-endocrine disorders that affect the quality of life of patients and reduces their working abi
Externí odkaz:
https://doaj.org/article/0557d09d409c4b78baf2e2bd5d38a0d3
Autor:
Shuya Kandori, Takayuki Yoshino, Masakazu Tsutsumi, Atsushi Yamauchi, Mikinobu Ohtani, Yoshiharu Fukuhara, Naoto Miyanaga, Jun Miyazaki, Hiroyuki Nishiyama, Toru Shimazui
Publikováno v:
Prostate International, Vol 4, Iss 4, Pp 140-144 (2016)
Background: We retrospectively analyzed castration-resistant prostate cancer (CRPC) patients treated with secondary hormonal therapies (SHTs) prior to docetaxel therapy. Methods: The cases of 73 CRPC patients who underwent docetaxel therapy in 2005
Externí odkaz:
https://doaj.org/article/095e82a947eb4993b30d3e1f0c95c755
Autor:
Hiroki Takagi, Miyuki Kajiwara, Irene Nowotny, Masanari Shiramoto, Hideya Muto, Wolfgang Schmider, Tatsuya Yoshihara
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports
Scientific Reports
This study compared the pharmacokinetic and glucodynamic profiles of biosimilar SAR341402 insulin aspart to Japan-approved insulin aspart (NovoRapid) in healthy Japanese males. In this single-center, randomized, double-blind, single-dose, two-period,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b35348be8171f6c2a176b21c9b5311
https://doaj.org/article/91ffc0df4bcd43f98107227aa96b64ad
https://doaj.org/article/91ffc0df4bcd43f98107227aa96b64ad